Brian Joseph Kieser

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Antonio, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Brian Joseph Kieser
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Brian Joseph Kieser

Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Convertible Promissory Note (the "Note")
Shares / value
1,666,667
Estimated value
$1,000,000
Report date
11 May 2026
Price
$0.6000
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Common Stock
Shares / value
133,216
Estimated value
$732,688
Report date
10 Nov 2026
Price
$5.50
Ownership
By Sequence LifeScience, Inc.
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Convertible Promissory Note (as amended)
Shares / value
1,000,000
Estimated value
Report date
10 Nov 2026
Price
Ownership
By Sequence LifeScience, Inc.
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Warrant to Purchase Common Stock (the "Warrant")
Shares / value
833,334
Estimated value
Report date
11 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Existing Warrant (as amended)
Shares / value
229,167
Estimated value
Report date
10 Nov 2026
Price
Ownership
By Sequence LifeScience, Inc.
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Convertible Promissory Note (as amended)
Shares / value
181,819
Estimated value
Report date
10 Nov 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Warrant to Purchase Common Stock (the "PIPE Warrant")
Shares / value
133,216
Estimated value
Report date
10 Nov 2026
Price
Ownership
By Sequence LifeScience, Inc.
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Existing Warrant (as amended)
Shares / value
41,667
Estimated value
Report date
10 Nov 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Convertible Promissory Note (before amendment)
Shares / value
0
Estimated value
Report date
10 Nov 2026
Price
Ownership
By Sequence LifeScience, Inc.
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Convertible Promissory Note (before amendment)
Shares / value
0
Estimated value
Report date
10 Nov 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Existing Warrant (before amendment)
Shares / value
0
Estimated value
Report date
10 Nov 2026
Price
Ownership
By Sequence LifeScience, Inc.
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim CEO, Director, 10%+ Owner

NEXGEL, INC.

Security class
Warrant to Purchase Common Stock
Shares / value
0
Estimated value
Report date
10 Nov 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Brian Joseph Kieser

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .